Molina Healthcare, Inc. (NYSE:MOH) Director Ronna Romney Sells 250 Shares

Molina Healthcare, Inc. (NYSE:MOH) Director Ronna Romney sold 250 shares of the business’s stock in a transaction on Saturday, December 29th. The shares were sold at an average price of $78.34, for a total transaction of $19,585.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Ronna Romney also recently made the following trade(s):

  • On Friday, December 29th, Ronna Romney sold 250 shares of Molina Healthcare stock. The shares were sold at an average price of $78.34, for a total transaction of $19,585.00.
  • On Friday, December 15th, Ronna Romney sold 250 shares of Molina Healthcare stock. The shares were sold at an average price of $74.53, for a total transaction of $18,632.50.
  • On Tuesday, November 14th, Ronna Romney sold 250 shares of Molina Healthcare stock. The shares were sold at an average price of $77.68, for a total transaction of $19,420.00.

Shares of Molina Healthcare, Inc. (NYSE:MOH) opened at $85.06 on Thursday. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $4,860.00, a PE ratio of -16.14, a P/E/G ratio of 1.08 and a beta of 0.97. Molina Healthcare, Inc. has a 52 week low of $42.56 and a 52 week high of $86.39.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The firm had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. During the same period in the prior year, the company posted $0.85 earnings per share. Molina Healthcare’s quarterly revenue was up 10.7% compared to the same quarter last year. equities analysts expect that Molina Healthcare, Inc. will post -3.88 EPS for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Zions Bancorporation bought a new stake in shares of Molina Healthcare during the third quarter valued at approximately $118,000. Tiedemann Wealth Management LLC grew its stake in shares of Molina Healthcare by 7.8% during the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock valued at $135,000 after purchasing an additional 103,775 shares during the last quarter. Riverhead Capital Management LLC grew its stake in shares of Molina Healthcare by 64.2% during the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after purchasing an additional 963 shares during the last quarter. Sabal Trust CO bought a new stake in shares of Molina Healthcare during the third quarter valued at approximately $206,000. Finally, Bronfman E.L. Rothschild L.P. grew its stake in shares of Molina Healthcare by 478.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock valued at $229,000 after purchasing an additional 2,743 shares during the last quarter. 96.22% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently commented on MOH. Leerink Swann boosted their price target on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday. Zacks Investment Research upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Monday, November 6th. Morgan Stanley boosted their target price on shares of Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. ValuEngine lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, Goldman Sachs Group initiated coverage on shares of Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. Molina Healthcare currently has an average rating of “Hold” and a consensus price target of $70.86.

COPYRIGHT VIOLATION WARNING: “Molina Healthcare, Inc. (NYSE:MOH) Director Ronna Romney Sells 250 Shares” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/11/insider-selling-molina-healthcare-inc-moh-director-sells-19585-00-in-stock.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply